Drugs selected for the FDA’s new Commissioner’s National Priority Review Voucher pilot program could receive a regulatory decision in two months or less. Qualifying product candidates must address a national priority, such as filling an unmet medical need or boosting domestic drug manufacturing.
The post FDA Unveils First 9 Picks for Pilot Program Speeding Up Review of ‘National Priority’ Products appeared first on MedCity News.
